These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 151900)

  • 1. Neocarzinostatin: initial clinical and pharmacologic studies in the United States.
    Comis RL; Griffin T; Raso V; Ginsberg SJ
    Recent Results Cancer Res; 1978; 63():261-71. PubMed ID: 151900
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunoassay of neocarzinostatin, a small cytotoxic protein used in cancer chemotherapy.
    Raso V
    Methods Enzymol; 1982; 84():483-90. PubMed ID: 6212749
    [No Abstract]   [Full Text] [Related]  

  • 3. Zinostatin (neocarzinostatin).
    Issell BF; Prestayko AW; Comis RL; Crooke ST
    Cancer Treat Rev; 1979 Dec; 6(4):239-49. PubMed ID: 161199
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of systemic administration of neocarzinostatin, a new protein antibiotic, on human bladder cancer.
    Sakamoto S; Ogata J; Ikegami K; Maeda H
    Cancer Treat Rep; 1978 Mar; 62(3):453-4. PubMed ID: 148320
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical investigations of neocarzinostatin in Japan.
    Kimura I
    Recent Results Cancer Res; 1978; 63():252-60. PubMed ID: 151899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for bladder cancer with neocarzinostatin: evaluation of systemic administration.
    Sakamoto S; Ogata J; Ikegami K; Maeda H
    Eur J Cancer (1965); 1980 Jan; 16(1):103-13. PubMed ID: 6444585
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I study of neocarzinostatin in patients with acute leukemia.
    Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1978 Sep; 62(9):1363-5. PubMed ID: 150945
    [No Abstract]   [Full Text] [Related]  

  • 8. Neocarzinostatin (NSC 157365) a new cancerostatic compound.
    Legha SS; Von Hoff DD; Rozencweig M; Abraham D; Slavik M; Muggia M
    Oncology; 1976; 33(5-6):265-70. PubMed ID: 141012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neocarzinostatin in cancer chemotherapy (review).
    Maeda H
    Anticancer Res; 1981; 1(3):175-86. PubMed ID: 6211130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of pancreatic carcinoma with neocarzinostatin].
    Kinami Y; Miyazaki H; Koyama F; Noguchi M; Konishi K
    Nihon Gan Chiryo Gakkai Shi; 1975 Dec; 10(4):502-8. PubMed ID: 130432
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of malignant glioma with neocarzinostatin. A combined chemoradiotherapy with intra-arterial neocarzinostatin perfusion and irradiation].
    Uemura S; Matsukado Y; Sonoda H; Kuratsu J; Ohtsuka T; Yoshioka S; Yoshida A; Kochi M; Marubayashi T
    Neurol Med Chir (Tokyo); 1986 Apr; 26(4):304-10. PubMed ID: 2429207
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clinical evaluation of a new antileukemic agent. 2) Neocarzinostatin (author's transl)].
    Kitajima K
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):767-72. PubMed ID: 4282818
    [No Abstract]   [Full Text] [Related]  

  • 13. Neocarzinostatin-induced complete regression of metastatic renal cell carcinoma.
    Satake I; Tari K; Yamamoto M; Nishimura H
    J Urol; 1985 Jan; 133(1):87-9. PubMed ID: 3155476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neocarzinostatin: a new agent active in the treatment of acute leukemia.
    Kitajima K; Kamimura O; Nagao T; Takahashi I; Hiraki K
    Bibl Haematol; 1975; (40):751-2. PubMed ID: 126059
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neocarzinostatin: molecular mechanism of action and prospects for clinical use].
    Köhnlein W; Jung G
    Arzneimittelforschung; 1982; 32(11):1474-9. PubMed ID: 6217819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of decrease of leukemic cells and leukocytes during neocarzinostatin treatment.
    Masaoka T; Hasegawa Y; Yoshitake J; Ueda T; Takubo T
    Cancer Treat Rep; 1977; 61(1):73-5. PubMed ID: 140763
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of acute leukemia with neocarzinostatin (NCS)].
    Masaoka T; Nakamura H; Hasegawa Y; Shibata H; Tatsumi N
    Rinsho Ketsueki; 1974 Dec; 15(12):1309-16. PubMed ID: 4282747
    [No Abstract]   [Full Text] [Related]  

  • 18. Caffeine potentiation on lethality of L-1210 cells treated with neocarzinostatin.
    Sasada M; Sawada H; Nakamura T; Uchino H
    Gan; 1976 Jun; 67(3):447-9. PubMed ID: 137161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of neocarzinostatin (NSC 157365) in malignant hepatoma. An Eastern Cooperative Oncology Group pilot study.
    Falkson G; Von Hoff D; Klaassen D; Du Plessis H; Van Der Merwe CF; Van Der Merwe AM; Carbone PP
    Cancer Chemother Pharmacol; 1980; 4(1):33-6. PubMed ID: 6244904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinostatin and doxorubicin. A combination phase I study.
    Issell BF; Ginsberg SJ; Comis RL
    Cancer Clin Trials; 1981; 4(3):323-6. PubMed ID: 6269771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.